UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000013010
Receipt number R000015190
Scientific Title Phase II study of bevacizumab in combined with carboplatin plus pemetrexed for patients with untreated non-squamous non-small cell lung cancer with brain metastases.
Date of disclosure of the study information 2014/02/01
Last modified on 2018/10/24 11:03:14

No. Disposal Last modified on Item of update
1 Insert 2014/01/29 23:05:24
2 Update 2015/08/14 12:49:29 Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Institute
Institute
Email1
3 Update 2018/10/24 11:03:14 Recruitment status